Wolverine Asset Management’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-387,700
| Closed | -$32.9M | – | 1863 |
|
|
2019
Q4 | $32.9M | Buy |
387,700
+29,200
| +8% | +$1.95M | 0.38% | 57 |
|
|
2019
Q3 | $17.9M | Buy |
358,500
+99,000
| +38% | +$3.95M | 0.23% | 87 |
|
|
2019
Q2 | $9.46M | Buy |
259,500
+101,500
| +64% | +$3.31M | 0.12% | 144 |
|
|
2019
Q1 | $4.42M | Buy |
158,000
+127,700
| +421% | +$3.01M | 0.06% | 248 |
|
|
2018
Q4 | $579K | Buy |
30,300
+3,000
| +11% | +$69.8K | 0.01% | 994 |
|
|
2018
Q3 | $816K | Hold |
27,300
| – | – | 0.01% | 880 |
|
|
2018
Q2 | $1M | Sell |
27,300
-11,900
| -30% | -$387K | 0.01% | 772 |
|
|
2018
Q1 | $1.29M | Sell |
39,200
-63,300
| -62% | -$1.98M | 0.02% | 681 |
|
|
2017
Q4 | $2.8M | Buy |
102,500
+39,200
| +62% | +$1.21M | 0.03% | 416 |
|
|
2017
Q3 | $2.34M | Hold |
63,300
| – | – | 0.03% | 448 |
|
|
2017
Q2 | $2.41M | Buy |
63,300
+4,000
| +7% | +$178K | 0.03% | 390 |
|
|
2017
Q1 | $2.9M | Buy |
59,300
+21,500
| +57% | +$981K | 0.05% | 311 |
|
|
2016
Q4 | $1.28M | Sell |
37,800
-20,500
| -35% | -$727K | 0.02% | 492 |
|
|
2016
Q3 | $2.2M | Buy |
58,300
+51,700
| +783% | +$1.95M | 0.03% | 384 |
|
|
2016
Q2 | $221K | Buy |
6,600
+6,534
| +9,900% | +$230K | ﹤0.01% | 860 |
|
|
2016
Q1 | $29K | Hold |
66
| – | – | ﹤0.01% | 941 |
|
|
2015
Q4 | $27K | Sell |
66
-269
| -80% | -$10.2K | ﹤0.01% | 1266 |
|
|
2015
Q3 | $33K | Sell |
335
-284
| -46% | -$9.97K | ﹤0.01% | 1371 |
|
|
2015
Q2 | $13K | Buy |
619
+5
| +0.8% | +$139 | ﹤0.01% | 1566 |
|
|
2015
Q1 | $53K | Buy |
+614
| New | +$17.2K | ﹤0.01% | 1242 |
|
Other funds holding MDCO
Wolverine Asset Management's MDCO Position: Q1 2019 in Review
Wolverine Asset Management sold out of Medicines Co (MDCO) in Q1 2019, closing a stake of 3,513 shares — an estimated $82.8K sold.
Wolverine Asset Management first reported a position in MDCO in Q4 2018 and held it in 1 quarter. The position peaked at $67K in Q4 2018. 203 funds tracked by Wall St. Rank hold MDCO as of Q1 2019.
- Wolverine Asset Management reported no remaining Medicines Co position as of Q1 2019 after selling out during the quarter.
- Wolverine Asset Management sold 3,513 Medicines Co shares in Q1 2019, an estimated $82.8K.
- Wolverine Asset Management first reported a position in Medicines Co in Q4 2018 and held it in 1 quarter.
- Wolverine Asset Management's Medicines Co position peaked at $67K in Q4 2018.
- 203 funds tracked by Wall St. Rank held Medicines Co as of Q1 2019.
Based on Wolverine Asset Management's 13F filing for Q1 2019, filed 15 May 2019.